canrenone has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baez, J; Byng, G; Laakso, JA; Mocek, UM; Preisig, CL; Wang, PT | 1 |
| Chłopicki, S; Drelicharz, L; Heinze-Paluchowska, S; Jabłońska, M; Skórka, T; Tyrankiewicz, U; Woźniak, M | 1 |
2 other study(ies) available for canrenone and cardiovascular agents
| Article | Year |
|---|---|
Biotransformations of the cardiovascular drugs mexrenone and canrenone.
Topics: Biotransformation; Canrenone; Cardiovascular Agents; Chromatography, High Pressure Liquid; Fermentation; Fungi; Magnetic Resonance Spectroscopy; Molecular Structure; Mortierella; Spironolactone; Stereoisomerism | 2003 |
The effect of the renin-angiotensin-aldosterone system inhibition on myocardial function in early and late phases of dilated cardiomyopathy in Tgaq*44 mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Canrenone; Cardiovascular Agents; Dobutamine; Heart Failure; Mice; Mice, Transgenic; Models, Animal; Perindopril; Renin-Angiotensin System | 2013 |